Literature DB >> 25179853

Expanding medical marijuana access in Canada: considerations for the rheumatologist.

Mary-Ann Fitzcharles1, Shahin Jamal2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25179853     DOI： 10.3899/jrheum.131514

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Authors:  J Ablin; P A Ste-Marie; M Schäfer; W Häuser; M-A Fitzcharles
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 2.  Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases.

Authors:  Mary-Ann Fitzcharles; Winfried Häuser
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

Review 3.  Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review.

Authors:  Ji-Yeun Park; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2017-05-16       Impact factor: 4.492

Review 4.  Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.

Authors:  M-A Fitzcharles; C Baerwald; J Ablin; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.